Direct intensity and phase modulation for quantum key distribution transmitters
Optics Express · 13.07.2026 · 34 (14) · 25039
DOI: 10.1364/oe.592737 ↗Kurz gefasst
Fachartikel in der Zeitschrift Optics Express, online erschienen am 29.06.2026. Verfasst von Hui Liu und 2 weiteren Autor:innen. Die Arbeit nennt 45 Literaturangaben. Gefördert von: Horizon Europe, Key Digital Technologies Joint Undertaking, NGF - Quantum Delta NL.
Abstract (Originalsprache)
The decoy-state method serves as a cornerstone for practical quantum key distribution (QKD) with inherent immunity to photon-number-splitting attacks. Leveraging optical injection locking, we propose a directly modulated light source with a scheme that simultaneously generates intensity- and phase-modulated signals without external modulators. Removing external modulators eliminates modulator-related side-channel vulnerabilities, fundamentally enhancing QKD security. Integrated into a high-speed phase-encoding BB84 system with optimized one-decoy protocol and finite-size analysis, our system achieves positive key rates up to 20 dB channel loss (100 km fiber) with commercial InGaAs single-photon detectors, reducing transmitter complexity while ensuring security for practical QKD applications.
Förderung
- Horizon Europe
- Key Digital Technologies Joint Undertaking
- NGF - Quantum Delta NL
Zitieren
APA
Liu, H., Nazarikov, G., & Tafur Monroy, I. (2026). Direct intensity and phase modulation for quantum key distribution transmitters. Optics Express, 34(14), 25039. https://doi.org/10.1364/oe.592737
Vancouver
Liu H, Nazarikov G, Tafur Monroy I. Direct intensity and phase modulation for quantum key distribution transmitters. Optics Express. 2026;34(14):25039. doi:10.1364/oe.592737
BibTeX
@article{Liu2026,
author = {Liu, Hui and Nazarikov, Gleb and Tafur Monroy, Idelfonso},
title = {Direct intensity and phase modulation for quantum key distribution transmitters},
journal = {Optics Express},
year = {2026},
volume = {34},
number = {14},
pages = {25039},
doi = {10.1364/oe.592737}
}
EUVIMED